Submit Content
Get the latest delivered to your inbox
Privacy Policy

CRB

CRB is a leading provider of sustainable engineering, architecture, construction and consulting solutions to the global life sciences and food and beverage industries. Our more than 1,600 employees provide world class solutions that drive success and positive change for our clients, our people and our communities. CRB is a privately held company with a rich history of serving clients throughout the world, consistently striving for the highest standard of technical knowledge, creativity and execution.

    Avid Bioservices, Inc. and CRB Highlight Efforts That Enabled Opening of First Phase of New Viral Vector Facility in California in Only Eight Months	 Image

    POSTED 

    06-22-22

    Avid Bioservices, Inc. and CRB Highlight Efforts That Enabled Opening of First Phase of New Viral Vector Facility in California in Only Eight Months

    Avid Bioservices, Inc. today highlighted the companies’ collaborative efforts that enabled the phase-one opening of its new purpose-built, 53,000-square-foot viral vector and CGMP facility in Costa Mesa, California, in only eight months.
    'Humanization of Pet Food' Driving New Capacity for Manufacturers, CRB Report Finds Image

    POSTED 

    05-23-22

    'Humanization of Pet Food' Driving New Capacity for Manufacturers, CRB Report Finds

    While many industries struggle with economic and market challenges, a new report from CRB finds that pet food manufacturers are racing to add capacity to meet consumer demand for high-quality products,
    Life Sciences and Pharmaceutical Industry's Need for Digitalization Adoption Image

    POSTED 

    04-26-22

    Life Sciences and Pharmaceutical Industry's Need for Digitalization Adoption

    “We are seeing more often that management is driving the adoption of digitalization in new facilities. It is becoming a standard and expected part of facility design,” shares Yvonne Duckworth
    The Need for Speed: How Operation Warp Speed Shifted the Pharma Industry Image

    POSTED 

    04-15-22

    The Need for Speed: How Operation Warp Speed Shifted the Pharma Industry

    CRB’s Christa Myers provides her insights from topics in our latest Horizons Life Sciences report including operation warp speed, project delivery strategy, and the digital future.
    In-house Production vs. CDMO: Meeting the Challenges of Commercializing Cell and Gene Therapies Image

    POSTED 

    04-05-22

    In-house Production vs. CDMO: Meeting the Challenges of Commercializing Cell and Gene Therapies

    Commercializing cell and gene therapies efficiently requires timely decisions about whether to engage a CDMO or develop internal manufacturing capacity. Sometimes the best solution is to do both.
    PPMOF Is Here to Stay Image

    POSTED 

    03-15-22

    PPMOF Is Here to Stay

    In the race to deliver an effective COVID-19 vaccine, strategies like PPMOF took the lead as roughly 90% of our clients relied on PPMOF strategy for pandemic-related projects.
    An Introduction to ATMP Manufacturing Image

    POSTED 

    02-15-22

    An Introduction to ATMP Manufacturing

    A cure for the previously incurable. That’s the big promise of Advanced Therapy Medicinal Products (ATMPs), and it’s attracting big numbers. In 2020 alone, the global ATMP industry raised $19.9B in annual financing, a 200% increase over 2019.
    The Dynamic Future of Life-Saving Medicine Image

    POSTED 

    02-14-22

    The Dynamic Future of Life-Saving Medicine

    For the five and a half billion people around the world who have so far received a COVID-19 vaccine, the FDA’s 2021 approval of Pfizer-BioNTech’s offering may not seem like a big deal.
    A Comprehensive Approach to Sustainability: Why It's No Longer Just a Nice-to-have Image

    POSTED 

    01-13-22

    A Comprehensive Approach to Sustainability: Why It's No Longer Just a Nice-to-have

    In our latest Horizons Report, we found that embracing sustainable change is no longer negotiable as 97% of life sciences companies report having committed to sustainability metrics – with three key factors driving these commitments.
    Swimming With the mRNA Current Image

    POSTED 

    01-11-22

    Swimming With the mRNA Current

    Bill Jarvis, our Senior Process Engineer, Sr. Associate, shares, "Those of us at CRB feel like we have grown up with the RNA industry; we’ve watched this technology space go from niche to one of the hottest areas of biopharma development."
    CRB logo

    CRB

    CRB

    Join today and get the latest delivered to your inbox